| Cellular component | cellular_component - GO:0005575; organelle - GO:0043226; intracellular part - GO:0044424; nuclear part - GO:0044428; nuclear speck - GO:0016607; cytoplasm - GO:0005737; intracellular organelle part - GO:0044446; nucleus - GO:0005634; cytoplasmic part - GO:0044444; nucleoplasm - GO:0005654; intracellular organelle - GO:0043229; organelle part - GO:0044422; membrane-bounded organelle - GO:0043227; cell part - GO:0044464; intracellular membrane-bounded organelle - GO:0043231; cytosol - GO:0005829; |
| Molecular function | transcription factor binding - GO:0008134; beta-catenin binding - GO:0008013; transcriptional activator activity; RNA polymerase II transcription regulatory region sequence-specific binding - GO:0001228; nucleic acid binding - GO:0003676; binding - GO:0005488; promoter-specific chromatin binding - GO:1990841; dna binding - GO:0003677; sequence-specific dna binding transcription factor activity - GO:0003700; molecular_function - GO:0003674; identical protein binding - GO:0042802; nucleic acid binding transcription factor activity - GO:0001071; heterocyclic compound binding - GO:1901363; sequence-specific DNA binding - GO:0043565; RNA polymerase II transcription factor activity; sequence-specific DNA binding - GO:0000981; protein binding - GO:0005515; organic cyclic compound binding - GO:0097159; transcription factor activity; sequence-specific DNA binding - GO:0003700; sequence-specific dna binding rna polymerase ii transcription factor activity - GO:0000981; DNA binding - GO:0003677; enzyme binding - GO:0019899; sequence-specific dna binding - GO:0043565; |
| Biological process | regulation of metabolic process - GO:0019222; positive regulation of gene expression - GO:0010628; regulation of multicellular organismal development - GO:2000026; negative regulation of mitotic cell cycle - GO:0045930; regulation of response to stimulus - GO:0048583; positive regulation of cellular process - GO:0048522; muscle structure development - GO:0061061; response to nutrient levels - GO:0031667; regulation of macromolecule metabolic process - GO:0060255; negative regulation of cellular process - GO:0048523; cellular macromolecule biosynthetic process - GO:0034645; regulation of vasculature development - GO:1901342; muscle organ development - GO:0007517; regulation of transcription; DNA-templated - GO:0006355; regulation of cellular process - GO:0050794; negative regulation of cell proliferation - GO:0008285; transcription from rna polymerase ii promoter - GO:0006366; cellular metabolic process - GO:0044237; regulation of macromolecule biosynthetic process - GO:0010556; anatomical structure development - GO:0048856; positive regulation of transcription; dna-templated - GO:0045893; macromolecule biosynthetic process - GO:0009059; protein deubiquitination - GO:0016579; negative regulation of muscle cell differentiation - GO:0051148; regulation of gene expression - GO:0010468; organic cyclic compound biosynthetic process - GO:1901362; neurotrophin signaling pathway - GO:0038179; neurotrophin trk receptor signaling pathway - GO:0048011; positive regulation of biosynthetic process - GO:0009891; enzyme linked receptor protein signaling pathway - GO:0007167; regulation of primary metabolic process - GO:0080090; nucleobase-containing compound metabolic process - GO:0006139; cell differentiation - GO:0030154; heterocycle biosynthetic process - GO:0018130; nucleic acid metabolic process - GO:0090304; metabolic process - GO:0008152; aromatic compound biosynthetic process - GO:0019438; nucleic acid-templated transcription - GO:0097659; intracellular signal transduction - GO:0035556; regulation of nitrogen compound metabolic process - GO:0051171; regulation of cell differentiation - GO:0045595; regulation of transcription from rna polymerase ii promoter - GO:0006357; organ development - GO:0048513; regulation of cell cycle process - GO:0010564; regulation of cellular biosynthetic process - GO:0031326; negative regulation of angiogenesis - GO:0016525; negative regulation of developmental process - GO:0051093; regulation of developmental process - GO:0050793; macromolecule metabolic process - GO:0043170; regulation of cell cycle - GO:0051726; fc-epsilon receptor signaling pathway - GO:0038095; positive regulation of macromolecule metabolic process - GO:0010604; mitotic dna integrity checkpoint - GO:0044774; regulation of rna metabolic process - GO:0051252; positive regulation of transcription from RNA polymerase II promoter - GO:0045944; innate immune response - GO:0045087; transcription from RNA polymerase II promoter - GO:0006366; cellular response to stress - GO:0033554; positive regulation of rna biosynthetic process - GO:1902680; regulation of immune system process - GO:0002682; signal transduction - GO:0007165; regulation of cell proliferation - GO:0042127; immune response-regulating signaling pathway - GO:0002764; immune system process - GO:0002376; positive regulation of biological process - GO:0048518; single-organism process - GO:0044699; nitrogen compound metabolic process - GO:0006807; positive regulation of cell cycle arrest - GO:0071158; rna biosynthetic process - GO:0032774; regulation of nucleic acid-templated transcription - GO:1903506; primary metabolic process - GO:0044238; negative regulation of G0 to G1 transition - GO:0070317; negative regulation of vasculature development - GO:1901343; mitotic g2/m transition checkpoint - GO:0044818; single-organism developmental process - GO:0044767; response to water-immersion restraint stress - GO:1990785; phosphatidylinositol-mediated signaling - GO:0048015; transcription; dna-templated - GO:0006351; positive regulation of rna metabolic process - GO:0051254; cellular aromatic compound metabolic process - GO:0006725; organic substance biosynthetic process - GO:1901576; negative regulation of g0 to g1 transition - GO:0070317; negative regulation of biological process - GO:0048519; regulation of angiogenesis - GO:0045765; cellular nitrogen compound metabolic process - GO:0034641; positive regulation of cellular metabolic process - GO:0031325; mitotic cell cycle process - GO:1903047; immune response - GO:0006955; positive regulation of macromolecule biosynthetic process - GO:0010557; positive regulation of nitrogen compound metabolic process - GO:0051173; cellular process - GO:0009987; negative regulation of cell differentiation - GO:0045596; transmembrane receptor protein tyrosine kinase signaling pathway - GO:0007169; positive regulation of cellular biosynthetic process - GO:0031328; negative regulation of cell cycle process - GO:0010948; biological_process - GO:0008150; fc receptor signaling pathway - GO:0038093; cellular nitrogen compound biosynthetic process - GO:0044271; negative regulation of smooth muscle cell differentiation - GO:0051151; negative regulation of cell cycle - GO:0045786; regulation of nucleobase-containing compound metabolic process - GO:0019219; regulation of muscle cell differentiation - GO:0051147; fibroblast growth factor receptor signaling pathway - GO:0008543; mitotic g2 dna damage checkpoint - GO:0007095; positive regulation of metabolic process - GO:0009893; negative regulation of multicellular organismal process - GO:0051241; negative regulation of blood vessel morphogenesis - GO:2000181; regulation of cellular metabolic process - GO:0031323; erbb signaling pathway - GO:0038127; regulation of rna biosynthetic process - GO:2001141; cellular response to dna damage stimulus - GO:0006974; regulation of transcription; dna-templated - GO:0006355; positive regulation of nucleic acid-templated transcription - GO:1903508; biosynthetic process - GO:0009058; cell surface receptor signaling pathway - GO:0007166; mitotic G2 DNA damage checkpoint - GO:0007095; regulation of biosynthetic process - GO:0009889; defense response - GO:0006952; cell cycle arrest - GO:0007050; negative regulation of transcription from RNA polymerase II promoter - GO:0000122; regulation of smooth muscle cell differentiation - GO:0051150; organic substance metabolic process - GO:0071704; regulation of immune response - GO:0050776; response to stress - GO:0006950; rna metabolic process - GO:0016070; positive regulation of nucleobase-containing compound metabolic process - GO:0045935; regulation of mitotic cell cycle - GO:0007346; organic cyclic compound metabolic process - GO:1901360; mitotic dna damage checkpoint - GO:0044773; cell cycle process - GO:0022402; cellular response to stimulus - GO:0051716; glucose homeostasis - GO:0042593; g2 dna damage checkpoint - GO:0031572; stem cell differentiation - GO:0048863; cellular developmental process - GO:0048869; cell cycle checkpoint - GO:0000075; positive regulation of smooth muscle cell migration - GO:0014911; regulation of biological process - GO:0050789; heterocycle metabolic process - GO:0046483; dna integrity checkpoint - GO:0031570; mitotic cell cycle checkpoint - GO:0007093; response to stimulus - GO:0050896; regulation of anatomical structure morphogenesis - GO:0022603; nucleobase-containing compound biosynthetic process - GO:0034654; developmental process - GO:0032502; dna damage checkpoint - GO:0000077; single-organism cellular process - GO:0044763; cellular macromolecule metabolic process - GO:0044260; biological regulation - GO:0065007; insulin receptor signaling pathway - GO:0008286; immune response-regulating cell surface receptor signaling pathway - GO:0002768; epidermal growth factor receptor signaling pathway - GO:0007173; cellular biosynthetic process - GO:0044249; aging - GO:0007568; regulation of multicellular organismal process - GO:0051239; regulation of g0 to g1 transition - GO:0070316; inositol lipid-mediated signaling - GO:0048017; regulation of cellular macromolecule biosynthetic process - GO:2000112; |
|---|